Amsterdam, the Netherlands– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of its Future Health Index 2024 report: Better care for more people. Launched at HLTH Europe, the ninth annual FHI global report shows that healthcare leaders are turning to virtual care and AI-enabled innovation to address pressure due to workforce shortages, financial burdens, and growing demand. June 18, 2024 Healthcare leaders indicate automation is crucial in addressing st ...

June 17, 2024 Increased control and efficiency with automated workflows In independent hands-on usability studies of clinicians from the US and EU with the Zenition 90 Motorized in simulated environments; 100% of users said that with the Table Side Operator, they have complete control over C-arm movements [2] and 97% report that workflow features such as Automatic Vascular Outlining will help save time during procedures [3]. [1]Also available in 15 kW [2] Results obtained during claims substantiation study ...

June 17, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help clinicians deliver high-quality care to more patients. Philips is partnering with its customers to improve productivity. The new mobile C-arm with expanded capabilities is designed to meet complex vascular needs, but also a range of clinical procedures such as cardia ...

In this regard, Philips' recent launch of the Duo Venous Stent System in a bid to boost its Image-Guided Therapy portfolio remains noteworthy. Expanding Portfolio & Partner Base Aid Diagnosis & Treatment Similarly, PHG also unveiled HealthSuite Imaging, an AI-enabled cloud-based Picture Archiving and Communication System, which offers high-speed remote diagnostic reading, integrated reporting and AIpowered workflow orchestration, enhancing operational efficiency and patient care. Bottom Line The strengtheni ...

The 12-month effectiveness endpoint for primary patency reached 90.2%, which exceeded the performance target goal of 77.3%. The 12-month primary safety endpoint of 98.7% also exceeded the corresponding performance goal of 89%. In addition, quality of life and venous functional assessments that were performed in the VIVID study – including Clinical-Etiology-Anatomy-Pathophysiology (CEAP), Venous Clinical Severity Score (VCSS), Villalta, EQ-5D-3L and VEINES scores – showed sustained improvements compared to b ...

Philips' (PHG) shares have gained 17.6% in the year-to-date period, outperforming the Zacks Medical sector's growth of 4.3%. The company is benefiting from strong momentum in the Diagnosis & Treatment segment on the back of its strengthening Precision Diagnosis portfolio powered by artificial intelligence (AI). The company's latest launch of an AI-enabled cardiovascular ultrasound platform testifies to the aforesaid fact. This FDA 510(k) cleared AI platform combines Philips' EPIQ CVx and Affiniti CVx ultras ...

June 4, 2024 New FDA-cleared AI-enabled applications include the industry's first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology issues in seconds First fully automated 3D quantification of mitral regurgitation (MR) volumes* designed to provide reproducible, efficient analysis helps clinicians make better-informed decisions for patients with heart valve disease Amsterdam, the Netherlands – Roya ...

May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustain ...

May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI operations, today announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet, which took place in Puerto Rico's Vida Imaging & Breast Center (Bayamón, Puerto Rico). Beyond its economic and sustain ...

Philips (PHG) is leaving no stone unturned to strengthen its footprint in the global medical imaging market on the back of a growing customer base. Per a Mordor Intelligence report, the global medical imaging market is expected to witness a CAGR of 4.9% between 2024 and 2030. Recently, the company announced the wide availability of its VeriSight Pro 3D Intracardiac Echocardiography catheter to several Hong Kong hospitals, thereby expanding clientele for its ICE imaging technology. Philips' VeriSight Pro 3D ...